A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm

ID Number 09-0997

Principal Investigator(s)
Michael C. Kim

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this study is to evaluate if the new Endeavor Resolute stent using a new polymer is safe and how effective the drug-eluting stent is in reducing the renarrowing in coronary arteries over time. Patients enrolled in the study will be treated with stents appropriate for the size of the area in the coronary artery that requires treatment and then assessed by the research nurse or doctor over the course of a 5 year period. ClinicalTrials.gov Identifier: NCT00726453

Contact Information
Kameswari Vallabhajosyula
(212) 241-5696

Recruiting Patients: No